MELBOURNE, Australia and INDIANAPOLIS, Jan. 12, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline...
Read More Details
Finally We wish PressBee provided you with enough information of ( Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform )
Also on site :
- Planting the seeds for remembering
- Prabowo hails BRICS entry, reaffirms Indonesia’s non-aligned stance
- Legendary ’70s Actor Seen in Rare Outing With Much Younger Girlfriend